MACLEODS PHARMS LTD FDA Approval ANDA 206879

ANDA 206879

MACLEODS PHARMS LTD

FDA Drug Application

Application #206879

Application Sponsors

ANDA 206879MACLEODS PHARMS LTD

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORAL400MG0NEVIRAPINENEVIRAPINE

FDA Submissions

UNKNOWN; ORIG1AP2017-10-06STANDARD
LABELING; LabelingSUPPL6AP2019-08-14STANDARD

Submissions Property Types

ORIG1Null15
SUPPL6Null15

TE Codes

001PrescriptionAB

CDER Filings

MACLEODS PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206879
            [companyName] => MACLEODS PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEVIRAPINE","activeIngredients":"NEVIRAPINE","strength":"400MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/06\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"08\/14\/2019","submission":"SUPPL-6","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-08-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.